American Portfolios Advisors Seres Therapeutics, Inc. Transaction History

American Portfolios Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 22, 2023	BUY	$18.46 - $24.36 $319,487 - $421,598	17,307 New	17,307 $413 Million
Q1 2021 Mar 22, 2023	BUY	$17.66 - $28.92 $299,478 - $490,425	16,958 New	16,958 $349 Million
Q4 2020 Mar 22, 2023	BUY	$23.25 - $37.73 $329,010 - $533,917	14,151 New	14,151 $347 Million
Q3 2020 Mar 22, 2023	BUY	$3.74 - $28.74 $34,950 - $268,575	9,345 New	9,345 $265 Million
Q2 2020 Mar 24, 2023	BUY	$3.04 - $6.2 $10,332 - $21,073	3,399 Added 332.26%	4,422 $21 Million
Q1 2020 Mar 24, 2023	BUY	$2.64 - $3.82 $2,700 - $3,907	1,023 New	1,023 $3.65 Million
Q2 2019 Mar 24, 2023	BUY	$2.28 - $7.35 $316 - $1,021	139 New	139 $448,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.